What is the most recent earnings date for DNMR stock?
DANIMER SCIENTIFIC INC (DNMR) last reported earnings on 11/19/2024.
DANIMER SCIENTIFIC INC (DNMR) Earnings History & Surprises
NYSE:DNMR • US2362721001
Current stock price
4.13 USD
-0.59 (-12.5%)
Last:
DNMR Earnings overview
Past quarterly earnings results for DANIMER SCIENTIFIC INC (DNMR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- N/A
- Period
- Q4 / 2024
- EPS Estimate
- -$6.60
- Revenue Estimate
- 11.266M
Last Reported
Most Recent- Release Date
- Nov 19, 2024
- Period
- Q3 / 2024
- EPS Reported
- -$4.80
- EPS Surprise
- 42.14%
- Revenue Surprise
- -1.34%
Beat Rate
Last 8 Quarters 38%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2024 | -4.80 | -8.30 | 42.14% | -1,130.77% | 8.63M | 8.747M | -1.34% | -21.17% |
| Q2 2024 | -7.60 | -9.38 | 19.01% | -1,900.00% | 7.628M | 9.455M | -19.32% | -40.71% |
| Q1 2024 | -0.26 | -0.27 | 2.59% | 27.78% | 10.224M | 11.285M | -9.40% | -14.27% |
| Q4 2023 | -0.39 | -0.39 | 0.17% | -39.29% | 10.945M | 11.56M | -5.32% | -28.56% |
| Q3 2023 | -0.39 | -0.35 | -12.46% | 58.51% | 10.948M | 15.037M | -27.19% | 4.77% |
| Q2 2023 | -0.38 | -0.37 | -2.44% | -26.67% | 12.865M | 14.177M | -9.25% | 1.30% |
| Q1 2023 | -0.36 | -0.39 | 7.36% | -38.46% | 11.926M | 14.683M | -18.78% | -19.09% |
| Q4 2022 | -0.28 | -0.29 | 4.24% | 17.65% | 15.32M | 16.764M | -8.61% | -13.59% |
| Q3 2022 | -0.94 | -0.18 | -425.86% | -370.00% | 10.45M | 12.771M | -18.17% | -21.84% |
| Q2 2022 | -0.30 | -0.24 | -22.55% | -25.00% | 12.7M | 15.664M | -18.92% | -12.23% |
| Q1 2022 | -0.26 | -0.24 | -9.64% | -100.00% | 14.74M | 21.831M | -32.48% | 11.84% |
| Q4 2021 | -0.34 | -0.30 | -12.36% | -9.68% | 17.73M | 18.043M | -1.73% | -62.54% |
| Q3 2021 | -0.20 | -0.09 | -130.68% | - | 13.37M | 14.855M | -10.00% | - |
| Q2 2021 | -0.24 | -0.07 | -236.13% | - | 14.47M | 12.036M | 20.22% | - |
| Q1 2021 | -0.13 | -0.06 | -112.42% | - | 13.18M | 12.24M | 7.68% | - |
| Q4 2020 | -0.31 | - | - | 47.33M | - | - | ||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
15.98%
Max EPS beat (4)
42.14%
Min EPS beat (4)
0.17%
Revenue beat statistics
Revenue beat (4)
0
Average Revenue beat (4)
-8.85%
Max Revenue beat (4)
-1.34%
Min Revenue beat (4)
-19.32%
Analysis
In the last 4 quarters, DNMR has consistently beaten EPS estimates in all releases
DNMR has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, DNMR has beaten the EPS estimates by 16.0% on average.
In the last 4 quarters, DNMR reported -8.8% below the revenue estimates on average.
Related analysis
DANIMER SCIENTIFIC INC / DNMR Earnings FAQ
Can you provide information on whether DANIMER SCIENTIFIC INC beat earnings estimates in the last quarter?
DANIMER SCIENTIFIC INC (DNMR) beat EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does DNMR stock beat earnings estimates?
In the last 4 quarters, DANIMER SCIENTIFIC INC (DNMR) has beaten EPS estimates in 4 out of 4 releases.